Company Profile
Globus Medical, Inc. is a US-based manufacturer of musculoskeletal solutions, headquartered at Valley Forge Business Center, 2560 General Armistead Avenue, Audubon, Pennsylvania 19403, United States. Founded in 2003 by David C. Paul, the company operates as an independent publicly traded entity on NYSE (GMED), led by President and CEO Keith W. Pfeil and Founder and Executive Chairman David C. Paul, serving hospitals, ambulatory surgery centers and surgeons in over 54 countries. The company employs approximately 6,000 staff and has launched more than 230 products worldwide.
Core Products ＆ Technologies
Spine ＆ Musculoskeletal Implants
• Traditional Fusion Implants: Pedicle screw and rod systems, plating systems, intervertebral spacers and corpectomy devices for degenerative, deformity, tumor and trauma conditions
• Motion Preservation Technologies: Dynamic stabilization, total disc replacement and interspinous distraction devices
• Interventional Solutions: Vertebral compression fracture treatment systems
• Regenerative Biologics: Allografts and synthetic alternatives for bone healing
• Trauma ＆ Joint Reconstruction: Orthopedic trauma implants and joint reconstruction systems
• Scripps Patient-Specific Lumbar Systems: Additively manufactured patient-matched interbody spacers and precision-bent rods, FDA 510(k) cleared in 2026, designed via Scripps Studio software and compatible with Excelsius navigation
Excelsius™ Technology Ecosystem
• ExcelsiusGPS™: The first robotic navigation platform combining a rigid robotic arm with full navigation capabilities for spine and cranial applications
• Excelsius3D™: An intelligent intraoperative imaging system consolidating three imaging modalities into one unit for multidisciplinary use
• ExcelsiusHub™: A freehand navigation system with real-time patient array monitoring and tissue-sparing drills for enhanced spine navigation safety
• ExcelsiusFlex™: A next-generation robotics platform for total knee arthroplasty and other joint replacement procedures
• ExcelsiusXR™: A wearable extended reality navigation headset blending visualization and control for surgeon ergonomics and workflow continuity
• CREO ONE™: The market's first robotic screw designed specifically for spine surgery with ExcelsiusGPS
Neuromodulation ＆ Pain Management
• Nevro Portfolio: High-frequency spinal cord stimulation systems for chronic pain management, acquired in 2025 and currently under integration with revised go-to-market strategy
• PRECICE™ Limb Lengthening: Motorized intramedullary nail systems for limb reconstruction, manufacturing fully insourced in early 2025 with output exceeding historical levels
Market Position ＆ Certifications
Globus Medical holds a leading position in the global spine market, competing with Medtronic, DePuy Synthes and Stryker. Key strengths include:
• 20+ years of US engineering heritage in spine and orthopedic innovation
• Excelsius ecosystem: Integrated robotics, navigation and imaging creating surgical workflow synergy and driving implant attach rates
• Comprehensive portfolio: One of the industry's broadest musculoskeletal solution sets spanning spine, trauma, enabling technologies and neuromodulation
• Regulatory compliance: FDA-cleared; CE marked for European and select global markets
• Global scale: Products commercially available across 54 countries with the majority of sales from the United States
• Consecutive growth: U.S. Spine business achieved 58 consecutive weeks of growth as of early 2026
Corporate Timeline
2003 — Founded by David C. Paul in Audubon, Pennsylvania with a mission to improve quality of life for patients with musculoskeletal disorders
2018 — Launches ExcelsiusGPS, the world's first robotic navigation platform combining a rigid robotic arm with full navigation for spine surgery
2021 — Introduces ExcelsiusGPS Cranial Solutions for deep brain stimulation, SEEG and biopsies; launches CREO ONE robotic screw
2023 — Completes merger with NuVasive, creating one of the industry's most comprehensive musculoskeletal solutions companies
2024 — Expands the Excelsius ecosystem with ExcelsiusFlex joint replacement robotics and ExcelsiusXR extended reality navigation
2025 — Acquires Nevro to expand into chronic pain neuromodulation; appoints Keith W. Pfeil as President and CEO; insources PRECICE manufacturing
2026 — FDA 510(k) clearance for Scripps patient-specific lumbar spacers and rods; U.S. Spine achieves 58 consecutive weeks of growth
Target Markets ＆ Applications
• Spine Fusion ＆ Deformity: Traditional and minimally invasive thoracolumbar and cervical fixation systems for degenerative and deformity correction procedures
• Motion Preservation: Total disc replacement and dynamic stabilization devices for active patients seeking alternatives to fusion
• Robotic-Assisted Surgery: ExcelsiusGPS and ExcelsiusFlex platforms for navigated pedicle screw placement and joint replacement in hospital and ASC settings
• Cranial ＆ Neurological: ExcelsiusGPS Cranial Solutions for stereotactic biopsy, shunt placement and deep brain stimulation electrode implantation
• Trauma ＆ Orthopedics: Fracture fixation, joint reconstruction and limb lengthening implants for emergency and elective orthopedic care
• Chronic Pain Management: Nevro high-frequency spinal cord stimulation for patients with chronic intractable pain
Contact Information
Global Headquarters
Address: Valley Forge Business Center, 2560 General Armistead Avenue, Audubon, Pennsylvania 19403, United States
Investor Relations
Stock: NYSE: GMED
Website: globusmedical.com
Investor Relations: ir.globusmedical.com
